These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29689479)

  • 1. Lipo-prostaglandin E1 improves renal hypoxia evaluated by BOLD-MRI in patients with diabetic kidney disease.
    Li ZC; Cai YZ; Tang ZG; Zuo PL; Liu RB; Liu F
    Clin Imaging; 2018; 50():239-242. PubMed ID: 29689479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E1 for preventing the progression of diabetic kidney disease.
    Wang H; Deng JL; Yue J; Li J; Hou YB
    Cochrane Database Syst Rev; 2010 May; (5):CD006872. PubMed ID: 20464745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of liposomal prostaglandin E1 on periprocedural myocardial injury in patients with unstable angina undergoing an elective percutaneous coronary intervention.
    Fan Y; Jiang Y; Fu X; Cai J; Wang Y; Li W; Gu X; Xing K; Bai S; Bi X
    Coron Artery Dis; 2015 Dec; 26(8):671-7. PubMed ID: 26267747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated Treatment of Prostaglandin E1 and Angiotensin-Converting Enzyme Inhibitor in Diabetic Kidney Disease Rats: Possible Role of Antiapoptosis in Renal Tubular Epithelial Cells.
    Mou Y; Zhang Y; Guo C; Zhao J; Zhang Z; Zhou X; Dong J; Liao L
    DNA Cell Biol; 2018 Feb; 37(2):133-141. PubMed ID: 29185789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy of different doses of lipo-prostaglandin E1 in the treatment of painful diabetic peripheral neuropathy.
    Hong L; Zhang J; Shen J
    J Diabetes Complications; 2015; 29(8):1283-6. PubMed ID: 26355026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical effect of treatment with lipo-prostaglandin E1 on the patients with chronic glomerulonephritis].
    Zhong WQ; Liu GX; Yang YM; Cai X; Huang ZL
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 May; 16(5):292-4. PubMed ID: 15132795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal Hypoxia: An Important Prognostic Marker in Patients with Chronic Kidney Disease.
    Zhou H; Yang M; Jiang Z; Ding J; Di J; Cui L
    Am J Nephrol; 2018; 48(1):46-55. PubMed ID: 30048964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive Evaluation of Renal Hypoxia by Multiparametric Functional MRI in Early Diabetic Kidney Disease.
    Wang R; Lin Z; Yang X; Zhao K; Wang S; Sui X; Su T; Wang X
    J Magn Reson Imaging; 2022 Feb; 55(2):518-527. PubMed ID: 34184356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long beneficial effects after lipo-prostaglandin E1 administration on the ischemic gastric tube in pigs.
    Ikeda Y; Morita N
    Dis Esophagus; 2008; 21(8):765-9. PubMed ID: 18564164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipo-PGE1, a new lipid-encapsulated preparation of prostaglandin E1: placebo-and prostaglandin E1-controlled multicenter trials in patients with diabetic neuropathy and leg ulcers.
    Toyota T; Hirata Y; Ikeda Y; Matsuoka K; Sakuma A; Mizushima Y
    Prostaglandins; 1993 Nov; 46(5):453-68. PubMed ID: 8278621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive evaluation of renal oxygenation in diabetic nephropathy by BOLD-MRI.
    Yin WJ; Liu F; Li XM; Yang L; Zhao S; Huang ZX; Huang YQ; Liu RB
    Eur J Radiol; 2012 Jul; 81(7):1426-31. PubMed ID: 21470811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Echocardiographic evaluation of the ductal morphology in patients with refractoriness to lipo-prostaglandin E1 therapy.
    Takeda N; Hiraishi S; Misawa H; Agata Y; Horiguchi Y; Fujino N; Hirota H; Kawamura S; Ogawa N
    Pediatr Int; 2000 Apr; 42(2):134-8. PubMed ID: 10804727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E1 in lipid microspheres ameliorates diabetic peripheral neuropathy: clinical usefulness of Semmes-Weinstein monofilaments for evaluating diabetic sensory abnormality.
    Akahori H; Takamura T; Hayakawa T; Ando H; Yamashita H; Kobayashi K
    Diabetes Res Clin Pract; 2004 Jun; 64(3):153-9. PubMed ID: 15126001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E1 attenuates high glucose-induced apoptosis in proximal renal tubular cells by inhibiting the JNK/Bim pathway.
    Zhang YH; Zhang YQ; Guo CC; Wang LK; Cui YJ; Dong JJ; Liao L
    Acta Pharmacol Sin; 2020 Apr; 41(4):561-571. PubMed ID: 31685975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of lipo-prostaglandin E1 on cystatin C, β2-microglobulin, and estimated glomerular filtration rate in patients with decompensated heart failure and renal dysfunction: a single-center, nonrandomized controlled study.
    Hou ZQ; Sun ZX; Su CY; Tan H; Zhong X; Hu B; Zhou Y; Shang DY
    Heart Vessels; 2013 Sep; 28(5):589-95. PubMed ID: 23000961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Renal Blood Flow and Oxygenation in CKD Using Magnetic Resonance Imaging.
    Khatir DS; Pedersen M; Jespersen B; Buus NH
    Am J Kidney Dis; 2015 Sep; 66(3):402-11. PubMed ID: 25618188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of age in determining the effects of lipo-PGE1 infusion on immediate arterial maximal flow velocity in patients with diabetes undergoing free flap surgery for lower extremity reconstruction: A prospective observational study.
    Park JY; Jin SJ; Suh HP; Lee SA; Cho C; Yu J; Hwang JH; Hong JP; Kim YK
    J Plast Reconstr Aesthet Surg; 2020 May; 73(5):885-892. PubMed ID: 31924534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of Renal Function in Patients with Diabetic Kidney Disease: A BOLD and DTI Study.
    Wei X; Hu R; Zhou X; Ni L; Zha D; Feng H; Xu H; Wu X
    Comput Intell Neurosci; 2022; 2022():6844102. PubMed ID: 36210998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effects of lipo-prostaglandin E1 on angiogenesis and neurogenesis after ischemic stroke in rats.
    Ling L; Zhang S; Ji Z; Huang H; Yao G; Wang M; He R; Deng W; Fang L
    Int J Neurosci; 2016; 126(5):469-77. PubMed ID: 26000823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of lipo-prostaglandin E1 on wound bed microcirculation.
    Hasegawa H; Ichioka S
    J Wound Care; 2015 Jul; 24(7):293-4, 296, 298-9. PubMed ID: 26198551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.